Forte Biosciences, Inc. (FBRX) Research & Development (2016 - 2020)
Forte Biosciences (FBRX) has disclosed Research & Development for 5 consecutive years, with $3.0 million as the latest value for Q4 2020.
- On a quarterly basis, Research & Development rose 161.23% to $3.0 million in Q4 2020 year-over-year; TTM through Dec 2020 was $10.0 million, a 272.73% increase, with the full-year FY2024 number at $20.7 million, down 5.25% from a year prior.
- Research & Development was $3.0 million for Q4 2020 at Forte Biosciences, down from $3.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $15.6 million in Q4 2018 to a low of -$11.2 million in Q3 2019.
- A 5-year average of $5.9 million and a median of $6.6 million in 2016 define the central range for Research & Development.
- Peak YoY movement for Research & Development: plummeted 191.49% in 2019, then skyrocketed 524.84% in 2020.
- Forte Biosciences' Research & Development stood at $6.6 million in 2016, then increased by 25.04% to $8.3 million in 2017, then skyrocketed by 88.32% to $15.6 million in 2018, then crashed by 92.59% to $1.2 million in 2019, then skyrocketed by 161.23% to $3.0 million in 2020.
- Per Business Quant, the three most recent readings for FBRX's Research & Development are $3.0 million (Q4 2020), $3.7 million (Q3 2020), and $1.9 million (Q2 2020).